Have a personal or library account? Click to login
Comparison Between Whole-Body MRI and PET/CT in Pediatric Oncology Cover

Comparison Between Whole-Body MRI and PET/CT in Pediatric Oncology

Open Access
|Jul 2018

References

  1. 1. Antoch G., Vogt FM., Freudenberg LS. et al. Wholebody dual-modality PET/CT and whole-body MRI for tumor staging in oncology // JAMA, 2003; 290:3199–206
  2. 2. Brennan D. D., Gleeson T, Coate LE, et al. A comparison of whole-body MRI and CT for the staging of lymphoma //AJR Am J Roentgenlogy, 2005;185(3):711—6
  3. 3. Canale S., Vilcot L., Ammari S. et al. Whole body MRI in pediatric oncology // Diagnostic and Interventional Imaging, 2014; 95, 541—55010.1016/j.diii.2013.11.00224704147
  4. 4. Chawla S. C., et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review // Pediatric Radiology, 2010 May; 40(5): 681–68610.1007/s00247-009-1434-z284716319967534
  5. 5. Chen Z., Li X., Fang Li, et al. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics // European Journal of Radiology, 2010; 75: 329–335
  6. 6. Ciliberto M. et al. Comparison between wholebody MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic review // Radiology and Oncology, 2013 Sep; 47(3): 206–21810.2478/raon-2013-0007379487524133384
  7. 7. CureSearch for childrens cancer – [viewed 28.12.2016.]. Accessed: http://curesearch.org/
  8. 8. ESMO 2016 Press Release: High response rate in phase I/II paediatric brain cancer trial sets stage for combination therapy with higher response and lower toxicity. October, 2016 – [viewed 06.03.2017.]. Accessed: http://www.esmo.org/Conferences/ESMO-2016-Congress/Press-Media/High-response-rate-in-phase-I-II-paediatric-brain-cancer-trial-sets-stage-for-combination-therapy-with-higher-response-and-lower-toxicity
  9. 9. Heindel W., Gübitz R., Vieth V., et al. The Diagnostic Imaging of Bone Metastases // Deutsches Ärzteblatt International, 2014;111(44):741-747
  10. 10. Klenk C., Gawande R., Uslu L. et al. Ionising radiation-free whole-body MRI versus 18F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, nonrandomised, single-centre study // Lancet Oncology, 2014; 15: 275–85
  11. 11. Krohmer S., Sorge I., Krausse A. et al. Whole-body MRI for primary evaluation of malignant disease in children // European Journal of Radiology, 2010; 74: 256–261
  12. 12. Kumar J., Seith A., Kumar A., et al. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT //Pediatric Radiology, 2008;38(9):953—62
  13. 13. Punwani S., Taylor SA., Bainbridge A., et al. Pediatric and adolescent lymphoma: comparison of whole-body STIR half-Fourier RARE MR imaging withan enhanced PET/CT reference for initial staging // Radiology, 2010;255(1):182—90
  14. 14. Robbins E. Radiation risks from imaging studies in children with cancer // Pediatric Blood Cancer, 2008; 51: 453–57
  15. 15. Schmidt GP, Baur-Melnyk A, Herzog P, et al. Highresolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomographycomputed tomography: experience on a 32-channel system // Investigative Radiology, 2005;40:743–53
  16. 16. Vandevoorde C. CT Protocols and CT Dose Contribution in PET/CT // iPET 2011 – Parallel Session IIIc, Panel Discussion: Practical Aspects of CT
DOI: https://doi.org/10.1515/chilat-2017-0011 | Journal eISSN: 2199-5737 | Journal ISSN: 1407-981X
Language: English
Page range: 15 - 17
Published on: Jul 17, 2018
Published by: Riga Stradins University
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2018 Anastasija Trofimovica, Ilze Apine, published by Riga Stradins University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.